EX02 CAR-T Cells for Relapsed and Refractory Acute Myeloid Leukemia
EX02 CAR-T Cells for Relapsed and Refractory Acute Myeloid Leukemia
Recruiting · NCT06642025 · Registry updated 2024-10-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| EX02 CAR-T Cells for Relapsed and Refractory Acute Myeloid Leukemia | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Recruiting | Early phase 1 | 2024-10-15 | NCT06642025 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Zeno Therapeutics Pte. Ltd | 3 |
| Zhimin Zhai | 2 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| The Second Affliated Hospital of Anhui Medical University | Hefei | China | 1 |